The Role of the Device Operating Under the Continuous Positive Airway Pressure in the Recovery Process of Cochlea
1 other identifier
interventional
45
1 country
1
Brief Summary
Hypothesis: Patients with obstructive sleep apnea syndrome (OSAS) have cochlear receptor cells damage because of prolonged, recurrent hypoxia. The use of devices operating under the continous positive airway pressure (CPAP) leads to the recovery of cochlear receptor cells. Aims:
- 1.To determinate whether there is cochlear receptor cells damage in OSAS patients depending on the degree of the disease
- 2.Investigate whether the use of ventilation devices with continuous positive pressure and constant oxygen pressure in the airways can lead to the recovery of the cochlear receptor cells Participants and Methods: The investigation work will be designed as original scientific research- prospective cohort study at Department od Otorhinolaryngology and Head and Neck Surgery, University Hospital Center Osijek.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 27, 2022
CompletedStudy Start
First participant enrolled
May 2, 2022
CompletedFirst Posted
Study publicly available on registry
May 5, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2024
CompletedJanuary 24, 2024
October 1, 2023
1.9 years
April 27, 2022
January 23, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Hearing test Otoacoustic Emission (TEOAE and DPOAE)
Objective analysis of hearing using otoacoustic emission in decibels. It is an objective method; it is performed by placing a probe with a plastic insertion into the subject's external ear canal and by recording the returning sound (an echo) with a sensitive microphone; the echo occurs in cases where the middle ear and cochlea i.e. cochlear receptor cells are healthy; the TEOAE shows the status of the whole cochlea, while the DPOAE examines more specific frequency regions.
45 minutes for each participant initialy and then after six to eight months of using device new measurement
Study Arms (2)
Patients with obstructive sleep apnea
EXPERIMENTALPatients with OSAS who have been previously examined by a neurologist for sleep disorders, have undergone polysomnography, and have been diagnosed with moderate severe obstructive sleep apnea according to the AHI index
Control Group
NO INTERVENTIONThe control group will consist of subjects in whom specific questionnaires excluded the existence of obstructive sleep apnea.
Interventions
The principle of operation is to prevent the closure and the narrowing of the structures of the upper respiratory tract by applying positive pressure. The device consists of a mask that protects the nose and/or mouth, a tube that connects the mask to the monitor and a monitor that blows air into the tube. A pressure in the range of 4 to 20 cm water is applied, depending on the individual needs of the patient to keep the airway open. The use is considered to be effective when the patient uses it continuously for at least 4 hours at bedtime. Today's modern devices have memory cards for storing data on the regularity and time of use of the device during the night and the efficiency of the device itself. For therapy to be considered effective, the number of apneas and hypopneas must be less than 5 per hour of sleep.
Eligibility Criteria
You may qualify if:
- Patients with OSAS who have been previously examined by a neurologist for sleep disorders, have undergone polysomnography, and have been diagnosed with moderate or severe obstructive sleep apnea according to the AHI index
- Healthy individuals for control group that will consist of subjects in whom specific questionnaires excluded the existence of obstructive sleep apnea.
You may not qualify if:
- age less than 18 years,
- persons with previous neurootological diseases that required surgical treatment
- persons who deviate from the research protocol.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Otorhinolaryngology and Head and Neck Surgery, University Hospital Center Osijek
Osijek, Croatia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Darija Birtic
Department of Otorhinolaryngology and Head and Neck Surgery Osijek
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Mirjana Grebenar Cerkez, M.D. ENT specialist, audiologist
Study Record Dates
First Submitted
April 27, 2022
First Posted
May 5, 2022
Study Start
May 2, 2022
Primary Completion
April 1, 2024
Study Completion
November 1, 2024
Last Updated
January 24, 2024
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, ICF, CSR
- Time Frame
- The data will be available upon completion of research for 12 months long
- Access Criteria
- The information will be shared with other potential researchers for further analyses
Plan is to share the results of pure tone audiometry and results of otoacoustic emission for each individuals in the study